Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study

Table 1

Clinical data and disease characteristics of the study group.

Age (years)	45.56 ± 5.44
Stage
I (a, b)	19 (36.5)
IIa	33 (63.5)
Time since diagnosis (months)	74.63 ± 11.32
Treatment modality
RH + BSO + PLND	48 (92.3)
RH + BSO + PLND + PALNS	4 (7.7)
Physical comorbidity
No	39 (75.0)
Yes	13 (25.0)

RH: radical hysterectomy; BSO: bilateral salpingooophorectomy; PLND: pelvic lymph node dissection; PALNS: para-aortic lymph node sampling. Data are shown as mean ± SD or as number (percentage).